Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Early Breast Cancer Treatment and Outcomes by Risk of Recurrence: A Retrospective US Electronic Health Records Study

Publication Date

2025

Content Type

Article

PubMed ID:

40507330

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS